Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection
The clinical assessment of response to neo-adjuvant therapy in patients with rectal cancer is an area that requires improvement due to overtreatment. ypT0N0 patients often have discordant investigations. Management decisions based on the concordance of investigations may reduce the number of ypT0N0 resections.
Authors
- Tracey Skinner
- Andrew Kneebone (ORCID: https://orcid.org/0000-0002-7629-504X)
- Keshani De Silva
- George Hruby (ORCID: https://orcid.org/0000-0003-4193-9682)
- Kah Hoong Chang
- Justin Evans
- Nick Pavlakis
- Yasser Salama
- Jonathan Hew
- Katerina Mastrocostas
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
Publication Details
- Journal
- International Journal of Colorectal Disease
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1007/s00384-025-05034-1
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00